States in U.S and Canada — Tax Credit Carryforward Amount
Roivant Sciences States in U.S and Canada — Tax Credit Carryforward Amount increased by 54.3% to $10.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 54.3%, from $7.00M to $10.80M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests the accumulation of unused tax incentives, while a decrease indicates the successful utilization of these credits to reduce tax expenses.
Detailed definition
This metric represents the total value of tax credits generated in the United States and Canada segment that have not ye...
Peer comparison
Peers in the biopharmaceutical sector often report similar carryforwards based on R&D tax credit programs, though amounts vary significantly based on clinical trial spending levels and regional tax legislation.
roiv_segment_united_states_and_canada_tax_credit_carryforward_amountHistorical Data
| Q1 '22 | Q1 '23 | Q1 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|
| Value | $27.20M | $37.60M | $45.30M | $7.00M | $10.80M |
| QoQ Change | — | +38.2% | +20.5% | -84.5% | +54.3% |
| YoY Change | — | +38.2% | +20.5% | -84.5% | +54.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's states in u.s and canada — tax credit carryforward amount?
- Roivant Sciences (ROIV) reported states in u.s and canada — tax credit carryforward amount of $10.80M in Q1 2026.
- How has Roivant Sciences's states in u.s and canada — tax credit carryforward amount changed year-over-year?
- Roivant Sciences's states in u.s and canada — tax credit carryforward amount increased by 54.3% year-over-year, from $7.00M to $10.80M.
- What does states in u.s and canada — tax credit carryforward amount mean?
- The total amount of unused tax credits in the U.S. and Canada that can be used to lower future tax payments.